MYOM2 and COVID-19: Based on recently reported epitope regions 1–20 and 201–222 of the M-protein for COVID-19 patients [30], we tested a total of six peptides corresponding mostly to the N-terminal region 1 to 21, the C-terminal region 173 to 222, and residues 101 to 113 synthesized in-house (Table S3).